| Title | Author(s) | Year | View Count |
 | Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay | Seto, WK; Tanaka, Y; Wong, DKH; Lai, CL; Shinkai, N; Yuen, JCH; Tong, T; Fung, J; Hung, IFN; Yuen, MF | 2013 | 76 |
 | Evidence of serologic activity in chronic hepatitis B after surface antigen (HBSAG) seroclearance | Seto, WK; Tanaka, Y; Wong, D; Lai, CL; Shinkai, N; Yuen, JCH; Tong, TSM; Fung, J; Hung, IFN; Yuen, MF | 2011 | 50 |
 | Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels | Yuen, MF; Tanaka, Y; Shinkai, N; Poon, RT; But, DYK; Fong, DYT; Fung, J; Wong, DKH; Yuen, JCH; Mizokami, M; Lai, CL | 2008 | 426 |
| Role of HBV genotypes, core promoter/precore mutations and HBV DNA levels on hepatocarcinogenesis | Yuen, RMF; Tanaka, Y; Shinkai, N; Poon, RTP; Fung, JYY; Wong, DKH; Yuen, JCH; Mizokami, M; Lai, CL | 2007 | 135 |
| Role of HBV genotypes, core promoter/precore mutations and HBV DNA levels on hepatocarcinogenesis | Yuen, RMF; Tanaka, Y; Shinkai, N; Poon, RTP; Fung, JYY; Wong, DKH; Yuen, JCH; Mizokami, M; Lai, CL | 2007 | 109 |
|
